Study Data


NMR Study

Project uploaded by: Neel Sarovar
Project ID: IMP_100036
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Project Description: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Research Area: Biological Sciences
Funding Source: JC bose fellowship, ICGEB core fund, Insitute of eminence, DU.
Project Contributors: Vishal Sharma , Anoop Singh , Sonam Sharma , Mohita Gaur , Arun Kumar Malaisamy , Deepti Rawat , Anjali Yadav , Bolaji Fatai Oyeyemi , Aarushi Vasudeva , Anil Chaudhry , Ashwani Khanna , Vishal Khanna , Sheelu Lohiya , Reema Arora , Anannya Bandyopadhyay , Neel Sarovar Bhavesh, Yogendra Singh, Richa Misra

Study uploaded by: Neel Sarovar
Study ID: IMS_100030
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Summary: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Keywords: Tuberculosis, diagnosis, pulmonary TB, extra-pulmonary TB, 1H NMR spectroscopy, gut metabolites
Publication: Metabolomics
Release Date: July 22, 2025
Study Type: Nuclear Magnetic Resonance (NMR)
Data Type: Untargeted
IEC/IBSC Approval Number : 2653/RBIPMT/2019

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
81 IMSM_101639 Exp 134 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA F 21 NA -80

NA

82 IMSM_101640 Exp 135 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA F 22 NA -80

NA

83 IMSM_101641 Exp 136 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA M 20 NA -80

NA

84 IMSM_101642 Exp 137 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA F 20 NA -80

NA

85 IMSM_101643 Exp 154 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA M 21 NA -80

NA

86 IMSM_101644 Exp 155 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA F 22 NA -80

NA

87 IMSM_101645 Exp 156 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA M 18 NA -80

NA

88 IMSM_101646 Exp 184 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA M 26 NA -80

NA

89 IMSM_101647 Exp 187 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA F 22 NA -80

NA

90 IMSM_101648 Exp 188 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. HC Healthy NA NA M 30 NA -80

NA

Sr.No NMR Exp ID Sample Name/ID Reference Standard NMR Instrument Name NMR Instrument Type NMR Experiment Type NMR Spectrometer Frequency NMR Probe NMR Probe temperature NMR Solvent NMR tube size Data Transformation (Software/s Used)
41 IME_100844 Exp 121 / IMSM_101599 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
42 IME_100845 Exp 122 / IMSM_101600 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
43 IME_100846 Exp 123 / IMSM_101601 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
44 IME_100847 Exp 124 / IMSM_101602 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
45 IME_100848 Exp 125 / IMSM_101603 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
46 IME_100849 Exp 126 / IMSM_101604 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
47 IME_100850 Exp 127 / IMSM_101605 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
48 IME_100851 Exp 129 / IMSM_101606 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
49 IME_100852 Exp 153 / IMSM_101607 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
50 IME_100853 Exp 157 / IMSM_101608 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA

Sr.No First name Last name Email Organization Designation
1 Richa Misra richamisra@svc.ac.in University of Delhi principal_investigator
2 Yogendra Singh ysinghdu@gmail.com University of Delhi co_principal_investigator
3 Neel Sarovar Bhavesh neelsb@icgeb.res.in ICGEB co_principal_investigator
4 Anannya Bandyopadhyay anannya@zoology.du.ac.in University of Delhi research_scholar
5 Reema Arora arorareema1569@gmail.com Lok Nayak Hospital research_scholar
6 Sheelu Lohiya drsheelulohiya@gmail.com Lok Nayak Hospital research_scholar
7 Vishal Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
8 Ashwani Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
9 Anil Chaudhry dranilchaudhry@gmail.com Rajan Babu Institute of Pulmonary Medicine and Tuberculosis research_scholar
10 Aarushi Vasudeva aarushi_vasudeva@yahoo.com University of Delhi research_scholar
11 Bolaji Fatai Oyeyemi bolajioyeyemi@gmail.com ICGEB research_scholar
12 Anjali Yadav anniey2411@gmail.com University of Delhi research_scholar
13 Deepti Rawat deeptirawat0397@gmail.com University of Delhi research_scholar
14 Arun Kumar Malaisamy makias191@gmail.com ICGEB research_scholar
15 Mohita Gaur m.mohitagaur@gmail.com University of Delhi research_scholar
16 Sonam Sharma sonamsharmamr@gmail.com ICGEB research_scholar
17 Anoop Singh anoop.singh.du@gmail.com University of Delhi research_scholar
18 Vishal Sharma s.vishalzoology@gmail.com University of Delhi research_scholar

Sr.No ftprun ID NMR Exp ID NMR Data Files
21 IMR_101423 IME_100824 212.zip
22 IMR_101424 IME_100825 215.zip
23 IMR_101425 IME_100826 216.zip
24 IMR_101426 IME_100827 217.zip
25 IMR_101427 IME_100828 228.zip
26 IMR_101428 IME_100829 229.zip
27 IMR_101429 IME_100830 230.zip
28 IMR_101430 IME_100831 231.zip
29 IMR_101431 IME_100832 232.zip
30 IMR_101432 IME_100833 233.zip